Literature DB >> 12390615

Sumatriptan scavenges superoxide, hydroxyl, and nitric oxide radicals: in vitro electron spin resonance study.

Yukio Ikeda1, Hiroyuki Jimbo, Motohiko Shimazu, Kazue Satoh.   

Abstract

BACKGROUND: The molecular mechanisms of migraine have not yet been clarified. Oxygen free radicals have been implicated in the genesis of many pathological processes, including migraine. Sumatriptan succinate is known to be a very effective drug for acute relief of migraine attack.
OBJECTIVE: To investigate the direct scavenging activities of sumatriptan for superoxide, hydroxyl, and nitric oxide (NO) radicals using electron spin resonance (ESR) spectroscopy.
METHODS: Measurement of superoxide and hydroxyl radical scavenging activities was performed by ESR using 5,5-dimethyl-1-pyrroline-N-oxide as a spin trap. NO was generated from 1-hydroxy-2-oxo-3-(N-3-methyl-3-aminopropyl)-3-methyl-1-triazene and analyzed by 2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl produced from the reaction between 2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide and NO.
RESULTS: The ESR study demonstrated that sumatriptan scavenged superoxide, hydroxyl, and NO in a dose-dependent manner.
CONCLUSIONS: Sumatriptan has direct scavenging activity on free radicals and NO. Acute migraine drugs with antioxidant properties may provide heretofore unheralded benefits via this mechanism.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12390615     DOI: 10.1046/j.1526-4610.2002.02208.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  7 in total

Review 1.  Nitric oxide-related drug targets in headache.

Authors:  Jes Olesen
Journal:  Neurotherapeutics       Date:  2010-04       Impact factor: 7.620

2.  Protective Roles of N-acetyl Cysteine and/or Taurine against Sumatriptan-Induced Hepatotoxicity.

Authors:  Javad Khalili Fard; Hossein Hamzeiy; Mohammadreza Sattari; Mohammad Ali Eghbal
Journal:  Adv Pharm Bull       Date:  2016-12-22

Review 3.  Emerging concepts in acute mountain sickness and high-altitude cerebral edema: from the molecular to the morphological.

Authors:  Damian Miles Bailey; Peter Bärtsch; Michael Knauth; Ralf W Baumgartner
Journal:  Cell Mol Life Sci       Date:  2009-09-10       Impact factor: 9.261

4.  Sumatriptan protects against myocardial ischaemia-reperfusion injury by inhibition of inflammation in rat model.

Authors:  Mohammad Sheibani; Hedyeh Faghir-Ghanesefat; Saman Dehpour; Hedieh Keshavarz-Bahaghighat; Mohammad Reza Sepand; Mohammad Hossein Ghahremani; Yaser Azizi; Nastaran Rahimi; Ahmad Reza Dehpour
Journal:  Inflammopharmacology       Date:  2019-03-30       Impact factor: 5.093

5.  Sumatriptan ameliorates renal injury induced by cisplatin in mice.

Authors:  Gholamreza Bazmandegan; Morteza Amirteimoury; Ayat Kaeidi; Ali Shamsizadeh; Morteza Khademalhosseini; Mohammad Hadi Nematollahi; Mahsa Hassanipour; Iman Fatemi
Journal:  Iran J Basic Med Sci       Date:  2019-05       Impact factor: 2.699

Review 6.  Harnessing Intranasal Delivery Systems of Sumatriptan for the Treatment of Migraine.

Authors:  Sara Assadpour; Mohammad Reza Shiran; Peyman Asadi; Javad Akhtari; Amirhossein Sahebkar
Journal:  Biomed Res Int       Date:  2022-01-15       Impact factor: 3.411

7.  A Pre-Existing Myogenic Temporomandibular Disorder Increases Trigeminal Calcitonin Gene-Related Peptide and Enhances Nitroglycerin-Induced Hypersensitivity in Mice.

Authors:  Hui Shu; Sufang Liu; Yuanyuan Tang; Brian L Schmidt; John C Dolan; Larry L Bellinger; Phillip R Kramer; Steven D Bender; Feng Tao
Journal:  Int J Mol Sci       Date:  2020-06-05       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.